Skip to content
Simpler Grants

No. HT942526ALSRPTIA · Defense Health Agency Contracting Activity - DHACA

Open

DoW Amyotrophic Lateral Sclerosis Research Program, Therapeutic Idea Award

grants.gov listing Full announcement (NOFO)
Dealbreakers No cost share required Audit: not stated Reimbursement-only: not stated
Invitation only
“Invitation to Submit an Application: August 3, 2026” — From the announcement
Award range
Not specified
Expected awards
~12
Application deadline
Sep 30, 2026 28 days left
Posted
May 4, 2026
Last verified
7 days ago

At a glance

AI summary

The Therapeutic Idea Award funds new, innovative, high-risk research aimed at ALS drug or therapy discovery, including investigational drug and medical device studies. Eligible applicants include extramural and intramural U.S. Department of War organizations, as well as foreign and domestic, for-profit and nonprofit, public and private organizations; awards are made to eligible organizations, not individuals. The program expects to fund about 12 awards with total costs capped at $840,000 per award, and the maximum period of performance is two years. Cost sharing is not required. There are no geographic restrictions stated, but clinical trials are not allowed, and projects involving animal models must follow specified research standards.

AI-generated summary — verify against the announcement

What it funds

  • Science and Technology and other Research and Development
  • Research & Discovery
  • Patients & People with Health Conditions
  • Biomedical & Disease Research
Official description from grants.gov

Summary: The fiscal year 2026 (FY26) Amyotrophic Lateral Sclerosis Research Program (ALSRP) Therapeutic Idea Award (TIA) supports new, innovative, high-risk, high-gain ideas aimed at amyotrophic lateral sclerosis (ALS) drug or therapy discovery. The studies supported by this award mechanism are expected to be hypothesis-driven and generate preliminary data for future avenues of therapeutic investigation. Distinctive Features: Potential impact and innovation are important features of the TIA. Applications may demonstrate the ability to achieve interpretable results in the absence of preliminary data supporting the hypothesis. While the inclusion of preliminary data is not prohibited, the strength of the application should rely on the approach.

Who can apply

  • Unrestricted
Geographic restriction None found in the announcement — likely nationwide

Program history

USASpending.gov

Assistance listing 12.420 · Military Medical Research and Development

Real awards this federal program has made — the whole assistance listing (12.420), not just this notice.

Fiscal year Awards Median award Middle half
FY 2026 (so far) 374 $934,195 $559,998 – $1,477,811
FY 2025 967 $796,174 $416,995 – $1,480,602
FY 2024 1,097 — —
FY 2023 1,115 — —
FY 2022 1,186 — —
FY 2021 1,023 — —

Dollar figures are based on the 1,000 most recent awards we store, not all 5,762 — award counts are complete.

Who wins it Business (127), Nonprofit (34), Higher education (2) of 5,762 awards — categories can overlap.
Top states CA (135) · TX (103) · NY (99) · MA (74) · MD (38)
Largest recent awards
  1. THE UNIVERISTY OF TEXAS M.D. ANDERSON CANCER CENTER $19,100,256 · FY 2025
  2. H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. $18,696,738 · FY 2025
  3. UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE $10,606,583 · FY 2025
  4. SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH $10,500,000 · FY 2026
  5. UNIVERSITY OF VERMONT & STATE AGRICULTURAL COLLEGE $8,491,997 · FY 2025

Source: USASpending.gov · refreshed Aug 25, 2026